Skip to main content
Premium Trial:

Request an Annual Quote

IncellDx PD-L1 Assay

IncellDx has released a new single-cell PD-L1 assay for research use only. The new "OncoTect iO Quantitative" test kit includes labeled antibodies to PD-L1 and CD45, CD8, and CD3 cell subsets as well as a DNA dye for cell cycle and quantitative detection of PD-L1 expression in non-small cell lung cancer tissue. According to the company, kits can be used on numerous samples types including FNA, core biopsies, and blood. The assay is also applicable to tumor types other than NSCLC including lung, bladder, and head and neck cancers.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.